位置:首页 > 蛋白库 > TYRDC_ENTFA
TYRDC_ENTFA
ID   TYRDC_ENTFA             Reviewed;         620 AA.
AC   Q838D6;
DT   13-NOV-2019, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2019, sequence version 2.
DT   03-AUG-2022, entry version 117.
DE   RecName: Full=L-tyrosine decarboxylase {ECO:0000303|PubMed:30659181};
DE            Short=TDC {ECO:0000303|PubMed:30659181};
DE            EC=4.1.1.25 {ECO:0000269|PubMed:30659181};
DE   AltName: Full=Levodopa decarboxylase {ECO:0000305|PubMed:30659181};
DE            Short=L-dopa decarboxylase {ECO:0000305|PubMed:30659181};
DE            EC=4.1.1.- {ECO:0000269|PubMed:30659181};
GN   Name=tdc {ECO:0000303|PubMed:30659181};
GN   Synonyms=tdcA {ECO:0000303|PubMed:25529314};
GN   OrderedLocusNames=EF_0634 {ECO:0000312|EMBL:AAO80459.1};
OS   Enterococcus faecalis (strain ATCC 700802 / V583).
OC   Bacteria; Firmicutes; Bacilli; Lactobacillales; Enterococcaceae;
OC   Enterococcus.
OX   NCBI_TaxID=226185;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 700802 / V583;
RX   PubMed=12663927; DOI=10.1126/science.1080613;
RA   Paulsen I.T., Banerjei L., Myers G.S.A., Nelson K.E., Seshadri R.,
RA   Read T.D., Fouts D.E., Eisen J.A., Gill S.R., Heidelberg J.F., Tettelin H.,
RA   Dodson R.J., Umayam L.A., Brinkac L.M., Beanan M.J., Daugherty S.C.,
RA   DeBoy R.T., Durkin S.A., Kolonay J.F., Madupu R., Nelson W.C.,
RA   Vamathevan J.J., Tran B., Upton J., Hansen T., Shetty J., Khouri H.M.,
RA   Utterback T.R., Radune D., Ketchum K.A., Dougherty B.A., Fraser C.M.;
RT   "Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus
RT   faecalis.";
RL   Science 299:2071-2074(2003).
RN   [2]
RP   FUNCTION, DISRUPTION PHENOTYPE, INDUCTION, AND PATHWAY.
RC   STRAIN=ATCC 700802 / V583;
RX   PubMed=25529314; DOI=10.1007/s00253-014-6301-7;
RA   Perez M., Calles-Enriquez M., Nes I., Martin M.C., Fernandez M., Ladero V.,
RA   Alvarez M.A.;
RT   "Tyramine biosynthesis is transcriptionally induced at low pH and improves
RT   the fitness of Enterococcus faecalis in acidic environments.";
RL   Appl. Microbiol. Biotechnol. 99:3547-3558(2015).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND ACTIVITY
RP   REGULATION.
RC   STRAIN=ATCC 700802 / V583;
RX   PubMed=30659181; DOI=10.1038/s41467-019-08294-y;
RA   van Kessel S.P., Frye A.K., El-Gendy A.O., Castejon M., Keshavarzian A.,
RA   van Dijk G., El Aidy S.;
RT   "Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the
RT   treatment of Parkinson's disease.";
RL   Nat. Commun. 10:310-310(2019).
CC   -!- FUNCTION: Catalyzes the decarboxylation of L-tyrosine to produce
CC       tyramine (PubMed:30659181). Plays a role in acid resistance since
CC       tyramine production via tyrosine decarboxylation appears to provide a
CC       cytosolic pH maintenance mechanism that helps the bacterium cope with
CC       acid stress such as that encountered in gastrointestinal tract (GIT)
CC       environments. Therefore, may contribute to the colonization of the
CC       human GIT by E.faecalis (PubMed:25529314).
CC       {ECO:0000269|PubMed:25529314, ECO:0000269|PubMed:30659181}.
CC   -!- FUNCTION: Also involved in drug metabolism, being able to catalyze
CC       decarboxylation of levodopa (L-dopa) to dopamine. In gut microbiota
CC       this enzyme is in fact exclusively responsible for the decarboxylation
CC       of levodopa, and thus reduces in situ levels of levodopa in the
CC       treatment of Parkinson's disease. It was shown that abundance of
CC       bacterial tyrosine decarboxylase in the proximal small intestine - the
CC       primary site of levodopa absorption - contributes to interindividual
CC       variation in drug efficacy and can explain the requirement for an
CC       increased dosage regimen of levodopa treatment in Parkinson's disease
CC       patients. {ECO:0000269|PubMed:30659181}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + L-tyrosine = CO2 + tyramine; Xref=Rhea:RHEA:14345,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:58315,
CC         ChEBI:CHEBI:327995; EC=4.1.1.25;
CC         Evidence={ECO:0000269|PubMed:30659181, ECO:0000305|PubMed:25529314};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14346;
CC         Evidence={ECO:0000269|PubMed:25529314};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + L-dopa = CO2 + dopamine; Xref=Rhea:RHEA:12272,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57504,
CC         ChEBI:CHEBI:59905; Evidence={ECO:0000269|PubMed:30659181};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12273;
CC         Evidence={ECO:0000305|PubMed:30659181};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000305|PubMed:30659181};
CC   -!- ACTIVITY REGULATION: Levodopa decarboxylation is not inhibited by
CC       carbidopa, benserazide, and methyldopa, that are three human L-dopa
CC       decarboxylase inhibitors. {ECO:0000269|PubMed:30659181}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.6 mM for L-tyrosine (at pH 5.0) {ECO:0000269|PubMed:30659181};
CC         KM=3 mM for L-dopa (at pH 5.0) {ECO:0000269|PubMed:30659181};
CC         Vmax=69.6 umol/min/mg enzyme for the decarboxylation of L-tyrosine
CC         (at pH 5.0) {ECO:0000269|PubMed:30659181};
CC         Vmax=35.3 umol/min/mg enzyme for the decarboxylation of L-dopa (at pH
CC         5.0) {ECO:0000269|PubMed:30659181};
CC         Note=kcat is 6963 min(-1) for the decarboxylation of L-tyrosine. kcat
CC         is 3531 min(-1) for the decarboxylation of L-dopa (at pH 5.0).
CC         {ECO:0000269|PubMed:30659181};
CC   -!- PATHWAY: Amino-acid metabolism. {ECO:0000269|PubMed:25529314}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:J7GQ11}.
CC   -!- INDUCTION: Up-regulated by tyrosine and acidic pH. Makes part of an
CC       operon together with tyrP and nhaC-2. {ECO:0000269|PubMed:25529314}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking the tdc cluster (tyrS, tdc/tdcA,
CC       tyrP and nhaC-2) lose the ability to produce tyramine, and show reduced
CC       viability under acidic pHs in the presence of tyrosine.
CC       {ECO:0000269|PubMed:25529314}.
CC   -!- SIMILARITY: Belongs to the group II decarboxylase family. Tyrosine
CC       decarboxylase subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAO80459.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE016830; AAO80459.1; ALT_INIT; Genomic_DNA.
DR   RefSeq; NP_814388.1; NC_004668.1.
DR   RefSeq; WP_002355450.1; NC_004668.1.
DR   AlphaFoldDB; Q838D6; -.
DR   SMR; Q838D6; -.
DR   STRING; 226185.EF_0634; -.
DR   EnsemblBacteria; AAO80459; AAO80459; EF_0634.
DR   GeneID; 60892923; -.
DR   KEGG; efa:EF0634; -.
DR   PATRIC; fig|226185.9.peg.582; -.
DR   eggNOG; COG0076; Bacteria.
DR   HOGENOM; CLU_005446_0_1_9; -.
DR   BRENDA; 4.1.1.25; 2095.
DR   Proteomes; UP000001415; Chromosome.
DR   GO; GO:0036468; F:L-dopa decarboxylase activity; IDA:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0004837; F:tyrosine decarboxylase activity; IDA:UniProtKB.
DR   GO; GO:1903184; P:L-dopa metabolic process; IDA:UniProtKB.
DR   Gene3D; 3.40.640.10; -; 1.
DR   InterPro; IPR002129; PyrdxlP-dep_de-COase.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR022397; Tyrosine_deCO2ase_bac.
DR   Pfam; PF00282; Pyridoxal_deC; 2.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   TIGRFAMs; TIGR03811; tyr_de_CO2_Ent; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Decarboxylase; Lyase; Pyridoxal phosphate; Reference proteome;
KW   Stress response.
FT   CHAIN           1..620
FT                   /note="L-tyrosine decarboxylase"
FT                   /id="PRO_0000448496"
FT   ACT_SITE        420
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:J7GQ11"
FT   BINDING         158..159
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000250|UniProtKB:J7GQ11"
FT   BINDING         298
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000250|UniProtKB:J7GQ11"
FT   BINDING         389..391
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000250|UniProtKB:J7GQ11"
FT   BINDING         440
FT                   /ligand="pyridoxal 5'-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:597326"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /evidence="ECO:0000250|UniProtKB:J7GQ11"
FT   MOD_RES         392
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:J7GQ11"
SQ   SEQUENCE   620 AA;  70053 MW;  A83C598048C7D5E1 CRC64;
     MKNEKLAKGE MNLNALFIGD KAENGQLYKD LLIDLVDEHL GWRQNYMPQD MPVISSQERT
     SESYEKTVNH MKDVLNEISS RMRTHSVPWH TAGRYWGHMN SETLMPSLLA YNFAMLWNGN
     NVAYESSPAT SQMEEEVGHE FAHLMSYKNG WGHIVADGSL ANLEGLWYAR NIKSLPFAMK
     EVKPELVAGK SDWELLNMPT KEIMDLLESA EDEIDEIKAH SARSGKHLQA IGKWLVPQTK
     HYSWLKAADI IGIGLDQVIP VPVDHNYRMD INELEKIVRG LAEEQIPVLG VVGVVGSTEE
     GAVDSIDKII ALRDELMKDG IYYYVHVDAA YGGYGRAIFL DEDNNFIPYE DLQDVHEEYG
     VFKEKKEHIS REVYDAYKAI ELAESVTIDP HKMGYIPYSA GGIVIQDIRM RDVISYFATY
     VFEKGADIPA LLGAYILEGS KAGATAASVW AAHHVLPLNV AGYGKLIGAS IEGSHHFYNF
     LNDLTFKVGD KEIEVHTLTH PDFNMVDYVF KEKGNDDLVA MNKLNHDVYD YASYVKGNIY
     NNEFITSHTD FAIPDYGNSP LKFVNSLGFS DEEWNRAGKV TVLRAAVMTP YMNDKEEFDV
     YAPKIQAALQ EKLEQIYDVK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024